Learn more at our upcoming exhibitions and conferences
Event type: Conference
Global DDF Summit
The Global DDF Summit is the premier drug delivery, formulation and device development event. With almost 100 sessions, 90 speakers, 4 content streams and dedicated networking breaks across three days, this is the perfect opportunity to share new ideas, discover the latest industry developments and overcome common challenges. The 2023 Summit will cover small molecules, biologics, device development and new technologies, concepts and case studies.
Event type: Exhibition
Modern Vaccines Adjuvants & Delivery Systems
The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2023 will offer researchers a fresh forum to discuss this important topic in detail. MVADS 2023 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.
Event type: Conference
Animal Health Nutrition and Technology Innovation
Shaping the future of the Animal Health Industry by showcasing innovations in prediction, prevention and treatment. The 6th Animal Health Innovation USA is the must attend networking event in North America for innovators with new solutions to support the detection, prevention or treatment of diseases in animals. Book a meeting with our Animal Health experts today.
Event type: Webinar
Large Scale Quantitative Imaging Mass Spectrometry of Lipids using MALDI and MALDI-2 using MSI Splash
Explore the lipidome with Shane Ellis, Associate Professor, University of Wollongong. Dr. Shane R. Ellis obtained his PhD in ambient ionization mass spectrometry of lipids from the University of Wollongong, Australia in 2013. He then began two-year postdoc at FOM-AMOLF (Amsterdam) working on the development of active pixel detectors for mass spectrometry and ion mobility. In 2014 he was appointed as assistant professor within the Maastricht MultiModal Molecular Institute (M4I) at Maastricht University, where he led the Instrumentation and Application Development group. Here, he established a world-leading group focusing on the development of advanced mass spectrometry imaging methods and their application to studying localized lipid metabolism within tissues. This work included leading several large development projects with mass spectrometry manufacturers. He has pioneered the development of several methods that provide ever-greater structural detail of lipids in imaging experiments, including the resolution of structural isomers. In 2020 he moved to University of Wollongong as an ARC Future Fellow, where he is establishing a mass spectrometry imaging group within the new Molecular Horizons Institute, focusing on both advancing the technology and its application to the life sciences.
View a selection of our past events
Event type: Exhibition
Formulation & Delivery UK
Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development. Welcoming key leaders across two cutting edge programmes highlighting new strategies for optimising biologic and chemical formulations, the latest developments in drug delivery and combination products, and the novel developmental strategies and technologies for a range of innovative new therapeutic modalities.
Event type: Webinar
Explore the Lipidome: Neurolipidomics revealed the cause of neurodegenerative bladder in Alzheimer's disease
Explore the lipidome with Xianlin Han, Professor of Medicine, University of Texas Health San Antonio. Xianlin is an internationally-renowned investigator in the fields of lipidomics, lipid metabolism, and lipid biochemistry. He has developed expertise in broad areas of research, such as neuroscience, diabetes, and metabolic biochemistry. The mass spectrometric techniques for lipidomics developed by their group, collectively termed “multi-dimensional mass spectrometry-based shotgun lipidomics” with unparalleled high sensitivity and comprehensive coverage, have been widely used to identify altered lipid metabolism, trafficking, and homeostasis, and biomarkers under patho(physio)logical conditions. The current interests of his laboratory research focus on Alzheimer’s disease, diabetic neuropathy, and mitochondrial dysfunction in diabetic hearts. As an investigator or co-investigator on over thirty previous NIH-funded grants, he has successfully produced multiple peer-reviewed publications from each project, resulting in a total of over 300 peer-reviewed publications. His contributions have received over 34,000 citations (over half are since 2015) with an h-index of 88 (Google Scholar, 2021).
Event type: Conference
Tides USA
Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products. Visit us at booth 316 to meet the team or schedule a meeting using the form below!
Event type: Webinar
Transforming Oral Drug Delivery
We are passionate about addressing formulation challenges and enhancing oral drug delivery, through our high purity excipients and Super Refined™ solutions. Our experts, Christian Wells and James Smith, Oriol Roigé invite you to attend our LIVE webinar created for small molecule formulators. Together we'll explore the key challenges faced in the oral drug delivery space and the solutions on offer. Don’t delay - register today!
Event type: Conference
Lyotalk Europe 2023 - Workshop with Andrew Bright
Andrew Bright, Research & Technology Specialist, is delivering a workshop on Formulation Development for Lypholised Pharmaceuticals. This workshop will provide guidance on how to determine the critical temperature of formulations and how to adjust the formulation to influence the critical temperature to make the freeze-drying process more efficient. And will discuss potential formulation screening methodologies, common decisions and issues which can occur during formulation development of freeze dried products.
Event type: Exhibition
Making Pharmaceuticals UK
The Leading UK Pharmaceutical Exhibition & Conference covering: Processing, Medical Devices, Regulatory, Clinical Testing, Research & Development, Operational Excellence, Pharmaceutical Quality, Serialisation, Clinical Trial Testing, Ingredients / Excipients, Microbiology And Pharma, Pharmaceutical Engineering, Packaging & Labelling, New Technologies, Data Management
Event type: Conference
LNP Formulation & Process Development Summit
Moving beyond mRNA vaccines, LNP is now giving scientists the opportunity to reimagine medicine, delivering curative and transformative treatment to patients. Emulating on the overwhelming success of LNP Formulation & Process Development Summit, the 2nd annual meeting returns to Boston in April as the one and only dedicated platform, uniting 350+ trailblazers, pioneers and new entrants to turbocharge next generation of LNP development. Visit us at booth 28 to meet the team or schedule a meeting using the form below!
Event type: Webinar
Unlocking novel vaccines of the future - understand our vaccines offering
Global experts, Peter Tygesen and Dr. Dennis Christensen invite you to attend our webinar created for the vaccine developers, exploring key challenges faced by formulators in this space and diving into the adjuvant system solutions provided by Croda Pharma, to unlock novel vaccines of the future. There is a missing link between academic research and readily available GMP vaccine adjuvants. Novel adjuvants are being researched intensely, they are desperately needed to initiate additional immune responses and administration routes, to name a few. If the industry can come together to bridge this gap it will make GMP vaccine adjuvants commercially available for all, imagine the innovation that can be achieved! Let us come together to explore the solutions. We are passionate about addressing this challenge. We are providing the GMP adjuvant solutions for vaccines of today and innovating to develop adjuvants that unlock new possibilities for the novel vaccines of tomorrow. Learn how our unique and comprehensive portfolio could unlock novel vaccines of the future. In this webinar you will learn about the key challenges for vaccine development, our comprehensive portfolio of Adjuvant Systems and how we partner to develop novel and tailored solutions.